JP2017186358A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017186358A5 JP2017186358A5 JP2017111470A JP2017111470A JP2017186358A5 JP 2017186358 A5 JP2017186358 A5 JP 2017186358A5 JP 2017111470 A JP2017111470 A JP 2017111470A JP 2017111470 A JP2017111470 A JP 2017111470A JP 2017186358 A5 JP2017186358 A5 JP 2017186358A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrate
- pharmaceutically acceptable
- acceptable salt
- compound
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 claims 1
- 241000711950 Filoviridae Species 0.000 claims 1
- 208000030156 Marburg disease Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462072331P | 2014-10-29 | 2014-10-29 | |
| US62/072,331 | 2014-10-29 | ||
| US201562105619P | 2015-01-20 | 2015-01-20 | |
| US62/105,619 | 2015-01-20 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017520938A Division JP6220484B1 (ja) | 2014-10-29 | 2015-10-29 | フィロウイルス科ウイルス感染症を処置するための方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020023613A Division JP2020090536A (ja) | 2014-10-29 | 2020-02-14 | フィロウイルス科ウイルス感染症を処置するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017186358A JP2017186358A (ja) | 2017-10-12 |
| JP2017186358A5 true JP2017186358A5 (cg-RX-API-DMAC7.html) | 2018-11-29 |
| JP6757294B2 JP6757294B2 (ja) | 2020-09-16 |
Family
ID=54557474
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017520938A Active JP6220484B1 (ja) | 2014-10-29 | 2015-10-29 | フィロウイルス科ウイルス感染症を処置するための方法 |
| JP2017520934A Active JP6487547B2 (ja) | 2014-10-29 | 2015-10-29 | リボシドの調製のための方法 |
| JP2017111470A Active JP6757294B2 (ja) | 2014-10-29 | 2017-06-06 | フィロウイルス科ウイルス感染症を処置するための方法 |
| JP2018129006A Active JP6671424B2 (ja) | 2014-10-29 | 2018-07-06 | リボシドの調製のための方法 |
| JP2019000664A Withdrawn JP2019048901A (ja) | 2014-10-29 | 2019-01-07 | リボシドの調製のための方法 |
| JP2020023613A Withdrawn JP2020090536A (ja) | 2014-10-29 | 2020-02-14 | フィロウイルス科ウイルス感染症を処置するための方法 |
| JP2020038878A Active JP7158428B2 (ja) | 2014-10-29 | 2020-03-06 | リボシドの調製のための方法 |
| JP2022019651A Withdrawn JP2022065066A (ja) | 2014-10-29 | 2022-02-10 | フィロウイルス科ウイルス感染症を処置するための方法 |
| JP2022024119A Pending JP2022068297A (ja) | 2014-10-29 | 2022-02-18 | リボシドの調製のための方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017520938A Active JP6220484B1 (ja) | 2014-10-29 | 2015-10-29 | フィロウイルス科ウイルス感染症を処置するための方法 |
| JP2017520934A Active JP6487547B2 (ja) | 2014-10-29 | 2015-10-29 | リボシドの調製のための方法 |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018129006A Active JP6671424B2 (ja) | 2014-10-29 | 2018-07-06 | リボシドの調製のための方法 |
| JP2019000664A Withdrawn JP2019048901A (ja) | 2014-10-29 | 2019-01-07 | リボシドの調製のための方法 |
| JP2020023613A Withdrawn JP2020090536A (ja) | 2014-10-29 | 2020-02-14 | フィロウイルス科ウイルス感染症を処置するための方法 |
| JP2020038878A Active JP7158428B2 (ja) | 2014-10-29 | 2020-03-06 | リボシドの調製のための方法 |
| JP2022019651A Withdrawn JP2022065066A (ja) | 2014-10-29 | 2022-02-10 | フィロウイルス科ウイルス感染症を処置するための方法 |
| JP2022024119A Pending JP2022068297A (ja) | 2014-10-29 | 2022-02-18 | リボシドの調製のための方法 |
Country Status (45)
Families Citing this family (124)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2480559B1 (en) | 2009-09-21 | 2013-07-03 | Gilead Sciences, Inc. | Processes and intermediates for the preparation of 1'-cyano-carbanucleoside analogs |
| PT2595980E (pt) | 2010-07-22 | 2014-11-27 | Gilead Sciences Inc | Métodos e compostos para tratar infeções pelo vírus da família paramyxoviridae |
| TWI740546B (zh) * | 2014-10-29 | 2021-09-21 | 美商基利科學股份有限公司 | 製備核糖苷的方法 |
| PL3349758T3 (pl) | 2015-09-16 | 2022-09-12 | Gilead Sciences, Inc. | Sposoby leczenia zakażeń wirusami arenaviridae |
| EP3538108A4 (en) * | 2016-11-10 | 2020-06-17 | Oyagen, Inc. | METHODS OF TREATING AND INHIBITING EBOLA VIRUS INFECTION |
| MX2019005675A (es) * | 2016-11-18 | 2019-08-14 | Neurovive Pharmaceutical Ab | Profarmacos hepaticos de ionoforos de protones mitocondriales. |
| KR102460968B1 (ko) | 2017-03-14 | 2022-11-01 | 길리애드 사이언시즈, 인코포레이티드 | 고양이 코로나바이러스 감염의 치료 방법 |
| JP6923112B2 (ja) * | 2017-03-31 | 2021-08-18 | 国立大学法人北海道大学 | フィロウイルスの細胞侵入阻害活性を有するビアリールスルフォンアミド誘導体 |
| JP2020518578A (ja) | 2017-05-01 | 2020-06-25 | ギリアード サイエンシーズ， インコーポレイテッド | （Ｓ）−２−エチルブチル２−（（（Ｓ）−（（（２Ｒ，３Ｓ，４Ｒ，５Ｒ）−５−（４−アミノピロロ［２，１−ｆ］［１，２，４］トリアジン−７−イル）−５−シアノ−３，４−ジヒドロキシテトラヒドロフラン−２−イル）メトキシ）（フェノキシ）ホスホリル）アミノ）プロパノエートの結晶形態 |
| CA3077489A1 (en) * | 2017-07-11 | 2019-01-17 | Gilead Sciences, Inc. | Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections |
| CR20200126A (es) | 2017-09-18 | 2020-07-11 | Janssen Biopharma Inc | Nucleósidos sustituidos, nucleótidos y análogos de estos |
| CN109535200A (zh) * | 2017-09-21 | 2019-03-29 | 杭州和正医药有限公司 | 一种核苷类似物的磷酰胺酯前药、药物组合物及其应用 |
| CN109748944B (zh) * | 2017-11-03 | 2021-12-10 | 中国科学院上海药物研究所 | 5’-脱氧-5’-异丙基取代氨基核苷类化合物、其制备方法和用途 |
| CN109748943A (zh) * | 2017-11-03 | 2019-05-14 | 中国科学院上海药物研究所 | 2’-c-甲基取代核苷类化合物及其制备与用途 |
| CN110330540A (zh) * | 2019-08-08 | 2019-10-15 | 木天(济南)生物科技有限公司 | 核苷盐及其制备方法 |
| CN110613726B (zh) * | 2019-09-25 | 2020-10-16 | 广州六顺生物科技股份有限公司 | 核苷化合物的应用 |
| WO2021095091A1 (ja) * | 2019-11-11 | 2021-05-20 | 藤本化学製品株式会社 | アミノアリール誘導体及びその中間体、並びにそれらの製造方法 |
| CN110776512A (zh) * | 2019-11-28 | 2020-02-11 | 成都傲飞生物化学品有限责任公司 | 一种核苷类似物的制备方法 |
| CN118766947A (zh) | 2020-01-27 | 2024-10-15 | 吉利德科学公司 | 用于治疗SARS CoV-2感染的方法 |
| US11738025B2 (en) | 2020-02-04 | 2023-08-29 | Oyagen, Inc. | Method for treating coronavirus infections |
| CN113214263B (zh) * | 2020-02-06 | 2022-09-30 | 北京桦冠医药科技有限公司 | 瑞德西韦关键中间体的一种合成方法 |
| US20210244705A1 (en) * | 2020-02-07 | 2021-08-12 | Centre For Digestive Diseases | Therapeutic compositions, products of manufacture and methods for ameliorating or preventing coronavirus infection |
| CN111205327B (zh) * | 2020-02-17 | 2022-05-31 | 南京法恩化学有限公司 | 一种瑞德西韦的制备方法 |
| TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| EP4644394A2 (en) | 2020-02-18 | 2025-11-05 | Gilead Sciences, Inc. | Antiviral compounds |
| TWI874791B (zh) * | 2020-02-18 | 2025-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI791193B (zh) | 2020-02-18 | 2023-02-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| CN113292565B (zh) * | 2020-02-24 | 2023-01-31 | 浙江森科建设有限公司 | 核苷类化合物及其制备方法和应用 |
| CN111171078B (zh) * | 2020-02-27 | 2022-04-22 | 江苏阿尔法药业股份有限公司 | 一种瑞德西韦的合成方法 |
| CN111187269A (zh) * | 2020-02-27 | 2020-05-22 | 江苏阿尔法药业有限公司 | 一种瑞德西韦中间体的合成方法 |
| CN111205294B (zh) * | 2020-02-27 | 2021-10-01 | 江苏阿尔法药业股份有限公司 | 一种瑞德西韦中间体的制备方法 |
| CN111233930B (zh) * | 2020-03-04 | 2022-05-13 | 江苏阿尔法药业股份有限公司 | 一种瑞德西韦的制备方法 |
| CN113354699B (zh) * | 2020-03-04 | 2023-07-18 | 中国科学院上海药物研究所 | 瑞德西韦的中间体及其制备方法 |
| CN111269248A (zh) * | 2020-03-05 | 2020-06-12 | 江苏福瑞康泰药业有限公司 | 一种核苷氨基磷酸酯类药物母液回收的新方法 |
| CN111269263A (zh) * | 2020-03-09 | 2020-06-12 | 上海龙翔生物医药开发有限公司 | 一种瑞德西韦侧链中间体及其制备方法 |
| CN111233870A (zh) * | 2020-03-11 | 2020-06-05 | 中国科学技术大学 | 用于快速制备瑞德西韦药物中间体的方法 |
| CN113387954B (zh) * | 2020-03-11 | 2024-03-19 | 上海特化医药科技有限公司 | 一种瑞德西韦中间体的制备方法 |
| CN111233869B (zh) * | 2020-03-12 | 2022-09-16 | 杭州新博思生物医药有限公司 | 用于制备瑞德西韦关键中间体的新化合物及其制备方法 |
| TWI890963B (zh) | 2020-03-12 | 2025-07-21 | 美商基利科學股份有限公司 | 1'-氰基核苷之製備方法 |
| CN113402546A (zh) * | 2020-03-17 | 2021-09-17 | 浙江四维医药科技有限公司 | 一种瑞德西韦磷酸中间体尾链动态动力学拆分方法 |
| JP2023518814A (ja) | 2020-03-23 | 2023-05-08 | ジェネンテック， インコーポレイテッド | Ｃｏｖｉｄ－１９肺炎における、ｉｌ－６アンタゴニストに対する応答を予測するためのバイオマーカー |
| JP2023518812A (ja) | 2020-03-23 | 2023-05-08 | ジェネンテック， インコーポレイテッド | Ｃｏｖｉｄ１９肺炎を治療するための、トシリズマブとレムデシビルとの組み合わせ |
| CN111233931B (zh) * | 2020-03-26 | 2022-03-22 | 宿迁盛基医药科技有限公司 | 一种瑞德西韦的合成方法 |
| CN111398464B (zh) * | 2020-04-02 | 2022-03-08 | 广州隽沐生物科技股份有限公司 | 2-乙基丁基（（全氟苯氧基）（苯氧基）磷酰基）-l-丙氨酸酯的检测方法 |
| CN113493480B (zh) * | 2020-04-03 | 2025-04-15 | 南京正大天晴制药有限公司 | 一种瑞德西韦异构体的制备及其分析方法 |
| CN111423443A (zh) * | 2020-04-03 | 2020-07-17 | 广州科锐特生物科技有限公司 | 一种4-氨基-7-碘吡咯并[2,1-f][1,2,4]三嗪的制备方法 |
| CN115362004A (zh) * | 2020-04-06 | 2022-11-18 | 吉利德科学公司 | 1’-氰基取代的碳核苷类似物的吸入制剂 |
| US12472197B2 (en) | 2020-04-07 | 2025-11-18 | Island Pharmaceuticals, Ltd. | Methods, compositions, and dosing regimens for treatment of SARS-CoV-2 infections |
| WO2021208910A1 (zh) * | 2020-04-13 | 2021-10-21 | 山东华铂凯盛生物科技有限公司 | 用于治疗病毒感染的聚合物制剂及制备方法和用途 |
| CN111393494A (zh) * | 2020-04-17 | 2020-07-10 | 广东帕派恩生物科技有限公司 | 基于核苷酸结构的化合物、制备方法、用途 |
| CN112778310B (zh) * | 2020-04-20 | 2025-05-30 | 中国科学院上海药物研究所 | 核苷类似物或含有核苷类似物的组合制剂在抗病毒中的应用 |
| CN115605492B (zh) * | 2020-04-21 | 2025-09-16 | 配体制药股份有限公司 | 核苷酸前药化合物 |
| CN111471070B (zh) * | 2020-04-26 | 2022-05-13 | 江苏阿尔法药业股份有限公司 | 瑞德西韦的合成方法 |
| CN111454270B (zh) * | 2020-04-27 | 2024-05-14 | 南通伟顺生物科技有限公司 | 一种含六元环的核苷类化合物及其制备方法 |
| CN111440176B (zh) * | 2020-04-28 | 2022-04-26 | 江苏大学 | 金属配合物促进的瑞德西韦中间体的合成方法 |
| US10988503B1 (en) * | 2020-05-06 | 2021-04-27 | Nantong Weishun Biotechnology Co., Ltd | Six-membered ring-containing nucleoside compound and preparation method thereof |
| CN113637041B (zh) * | 2020-05-11 | 2024-02-27 | 上海科胜药物研发有限公司 | 一种核糖核苷的制备方法 |
| RU2740660C1 (ru) * | 2020-05-20 | 2021-01-19 | Общество С Ограниченной Ответственностью "Промомед Рус" | Противовирусная композиция |
| US20230277524A1 (en) | 2020-05-22 | 2023-09-07 | Trailhead Biosystems Inc. | Combination therapy for treatment of viral infections |
| CN111961057A (zh) * | 2020-05-26 | 2020-11-20 | 李小冬 | 一种α构型核苷及其在治疗猫冠状病毒感染的应用 |
| ES3041698T3 (en) | 2020-05-29 | 2025-11-13 | Gilead Sciences Inc | Remdesivir for the treatment of viral infections |
| WO2021240543A1 (en) | 2020-05-29 | 2021-12-02 | Jubilant Generics Limited | Transmucosal pharmaceutical compositions of antiviral drugs |
| IN202011022634A (cg-RX-API-DMAC7.html) | 2020-05-29 | 2020-10-09 | Jubilant Generics Limited | |
| CN113754692B (zh) * | 2020-06-03 | 2022-06-10 | 上海交通大学 | 瑞德西韦中间体(s,s)-氨基磷酸酯的不对称催化合成方法 |
| CN113754694B (zh) * | 2020-06-03 | 2022-10-25 | 上海交通大学 | 一种不对称催化无保护基核苷合成瑞德西韦的方法 |
| CN113754693B (zh) * | 2020-06-03 | 2022-09-09 | 上海交通大学 | 一种磷手性核苷衍生物的不对称催化合成方法及催化剂 |
| WO2021257569A1 (en) * | 2020-06-15 | 2021-12-23 | Metro International Biotech, Llc | Anti-viral compounds and methods of use |
| US20230241225A1 (en) | 2020-06-15 | 2023-08-03 | Metro International Biotech, Llc | Anti-viral compounds and methods of use |
| CN111620903A (zh) * | 2020-06-17 | 2020-09-04 | 安徽贝克联合制药有限公司 | C-核苷类似物以及用于合成瑞德西韦合成的含腈c-核苷类化合物的制备方法及其应用 |
| US20210393663A1 (en) * | 2020-06-23 | 2021-12-23 | Cai Gu Huang | Pharmaceutical formulation containing active metabolites of remdesivir or its analog for inhalation |
| JP2023531524A (ja) | 2020-06-24 | 2023-07-24 | ギリアード サイエンシーズ， インコーポレイテッド | １’－シアノヌクレオシド類似体及びその使用 |
| CN111732618A (zh) * | 2020-07-03 | 2020-10-02 | 镇江巨杰新材料技术研发中心(有限合伙) | 瑞德西韦关键片段的合成方法 |
| CN111961079A (zh) * | 2020-07-17 | 2020-11-20 | 南京正济医药研究有限公司 | 一种瑞德西韦有关物质及其制备方法和应用 |
| EP4185300A4 (en) * | 2020-07-24 | 2024-09-25 | The Regents of the University of California | ANTIVIRAL PRODRUGS, PHARMACEUTICAL FORMULATIONS AND METHODS |
| CA3185450A1 (en) | 2020-08-06 | 2022-02-10 | Istvan Borza | Remdesivir intermediates |
| CN113004330A (zh) * | 2020-08-22 | 2021-06-22 | 齐鲁制药有限公司 | 一种高纯度瑞德西韦的制备方法 |
| JP7559223B2 (ja) * | 2020-08-24 | 2024-10-01 | ギリアード サイエンシーズ， インコーポレイテッド | リン脂質化合物及びその使用 |
| IL300453A (en) * | 2020-08-27 | 2023-04-01 | Gilead Sciences Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS |
| CN114105989A (zh) * | 2020-08-31 | 2022-03-01 | 中国科学院大连化学物理研究所 | 一种碘代吡咯并三嗪胺类化合物的制备方法和应用 |
| EP4213877A1 (en) | 2020-09-17 | 2023-07-26 | Genentech, Inc. | Results of empacta: a randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of tocilizumab in hospitalized patients with covid-19 pneumonia |
| CN112321642A (zh) * | 2020-09-28 | 2021-02-05 | 南京正济医药研究有限公司 | 一种瑞德西韦有关物质及其制备方法和用途 |
| WO2022074630A1 (en) * | 2020-10-09 | 2022-04-14 | Auxilla Pharmaceuticals And Research Llp | Liquid oral suspension of favipiravir |
| CN112194661B (zh) * | 2020-10-22 | 2021-06-08 | 威海同丰海洋生物科技有限公司 | 一种4-氨基-7-碘吡咯并[2,l-f][l,2,4]三嗪的制备方法 |
| JP7711900B2 (ja) * | 2020-10-26 | 2025-07-23 | 蘇州旺山旺水生物医薬股▲ふん▼有限公司 | ヌクレオシド類似体の塩及びその結晶形、医薬組成物並びに用途 |
| CN114507256B (zh) * | 2020-11-16 | 2025-02-28 | 上海医药集团股份有限公司 | 一种瑞德西韦工艺手性异构体、其制备方法及其应用 |
| RU2756921C1 (ru) * | 2020-11-20 | 2021-10-07 | Общество С Ограниченной Ответственностью "Технология Лекарств" | Способ получения ремдесивира и фосфорамидаты |
| MX2023005878A (es) | 2020-11-23 | 2023-06-05 | Genentech Inc | Metodos para modular las interacciones de la superficie de la celula huesped con sars-cov-2. |
| CN112358513A (zh) * | 2020-12-02 | 2021-02-12 | 上海朴颐化学科技有限公司 | 一种利用连续流反应器制备瑞德西韦中间体的方法 |
| CN114621229B (zh) * | 2020-12-11 | 2024-07-02 | 嘉兴金派特生物科技有限公司 | 治疗或预防猫传染性腹膜炎的化合物或组合物 |
| CN114644666A (zh) * | 2020-12-18 | 2022-06-21 | 上海特化医药科技有限公司 | 5’-核苷前药的制备方法及中间体 |
| CN114685511A (zh) * | 2020-12-25 | 2022-07-01 | 上海科胜药物研发有限公司 | 一种瑞德西韦中间体的纯化方法 |
| CN114685558A (zh) * | 2020-12-28 | 2022-07-01 | 尚科生物医药（上海）有限公司 | 一种瑞德西韦中间体的制备方法 |
| WO2022142477A1 (en) * | 2020-12-30 | 2022-07-07 | Southern University Of Science And Technology | Methods and modified nucleosides for treating coronavirus infections |
| CN113754665B (zh) * | 2020-12-30 | 2022-08-19 | 南方科技大学 | 一种核苷类化合物的制备方法 |
| US11998562B2 (en) | 2021-01-25 | 2024-06-04 | University Of South Florida | Ophthalmological formulations for the prevention of a coronavirus infection |
| WO2022166581A1 (zh) * | 2021-02-07 | 2022-08-11 | 石家庄迪斯凯威医药科技有限公司 | 一种核苷酸衍生物及其药物组合物和用途 |
| WO2022174779A1 (zh) * | 2021-02-19 | 2022-08-25 | 南京赛弗斯医药科技有限公司 | 一种具有抗肿瘤活性的核苷酸衍生物及其药物组合物和用途 |
| CN112979736B (zh) * | 2021-03-04 | 2022-03-25 | 南京欧信医药技术有限公司 | 一种瑞德西韦的制备方法 |
| CN115109077A (zh) * | 2021-03-18 | 2022-09-27 | 上海医药集团股份有限公司 | 瑞德西韦中间体的制备方法 |
| KR20230170745A (ko) | 2021-04-16 | 2023-12-19 | 길리애드 사이언시즈, 인코포레이티드 | 아미드를 사용한 카르바뉴클레오시드를 제조하는 방법 |
| JP7684428B2 (ja) | 2021-04-16 | 2025-05-27 | ギリアード サイエンシーズ， インコーポレイテッド | アミドを使用してカルバヌクレオシドを調製する方法 |
| EP4346772A1 (en) | 2021-05-26 | 2024-04-10 | Gilead Sciences, Inc. | Phospholipid formulations of 1'-cyano substituted carba-nucleoside analogs |
| CN113683640B (zh) * | 2021-08-10 | 2025-01-14 | 浙江华海药业股份有限公司 | 一种丁基瑞德西韦的制备方法 |
| WO2023023527A1 (en) | 2021-08-18 | 2023-02-23 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
| CN118119624A (zh) | 2021-08-20 | 2024-05-31 | 盐野义制药株式会社 | 具有病毒增殖抑制作用的核苷衍生物及其前药 |
| CN113999237B (zh) * | 2021-10-29 | 2023-08-08 | 润佳（苏州）医药科技有限公司 | 一种核苷类前药及其用途 |
| KR102675967B1 (ko) | 2021-11-02 | 2024-06-17 | 충남대학교산학협력단 | 렘데시비르를 함유하는 나노지질담체, 이의 제조방법 및 이를 포함하는 약학적 조성물 |
| CN114409655A (zh) * | 2022-01-26 | 2022-04-29 | 郑州大学 | 3′,4′-不饱和核糖c-核苷类似物及其制备方法 |
| TW202525810A (zh) | 2022-03-02 | 2025-07-01 | 美商基利科學股份有限公司 | 用於治療病毒感染的化合物及方法 |
| CN115028672A (zh) * | 2022-06-14 | 2022-09-09 | 南京正济医药研究有限公司 | 瑞德西韦中间体晶体及其制备方法 |
| CN116874491A (zh) * | 2022-07-12 | 2023-10-13 | 深圳安泰维生物医药有限公司 | 一种n-保护的吡咯并三嗪碳苷类化合物及其制备方法 |
| US11655255B2 (en) | 2022-10-17 | 2023-05-23 | Sph No.1 Biochemical & Pharmaceutical Co., Ltd. | Method for catalytic asymmetric synthesis of phosphorus-stereogenic (P-stereogenic) nucleoside derivative and catalyst used therein |
| KR20250109707A (ko) | 2022-11-18 | 2025-07-17 | 길리애드 사이언시즈, 인코포레이티드 | 폭스바이러스 감염을 치료하는 방법 |
| CN115737675B (zh) * | 2022-11-28 | 2024-03-08 | 安徽农业大学 | 氧化型硒代硫酸钠的制备及其在治疗冠状病毒感染中的应用 |
| CN115947759A (zh) * | 2022-12-13 | 2023-04-11 | 安徽大学 | 一种治疗新冠药物瑞德西韦的制备方法 |
| CN116284135B (zh) * | 2023-05-04 | 2025-03-21 | 南京颐媛生物医学研究院有限公司 | 抗冠状病毒核苷类化合物的制备方法及其应用 |
| CN116332996B (zh) * | 2023-05-04 | 2025-04-01 | 南京颐媛生物医学研究院有限公司 | L-呋喃核糖型抗冠状病毒化合物及其制备方法和应用 |
| HUP2300153A1 (hu) | 2023-05-09 | 2024-11-28 | Rotachrom Tech Zrt | Eljárás remdesivir foszfor sztereoizomereinek elválasztására akirális folyadék-folyadék kromatográfiával |
| CN116554176A (zh) * | 2023-05-11 | 2023-08-08 | 南京正济医药研究有限公司 | 一种核苷类化合物的制备方法 |
| CN117126199B (zh) * | 2023-05-17 | 2024-12-06 | 江西师范大学 | 一种氟代瑞德西韦合成方法 |
| CN117343114A (zh) * | 2023-09-22 | 2024-01-05 | 山东大学 | 一种高立体选择性的α-木糖吡喃糖苷键构建方法 |
| WO2025072641A1 (en) | 2023-09-28 | 2025-04-03 | Gilead Sciences, Inc. | Compounds and methods for treatment of viral infections |
| CN117800872A (zh) * | 2023-12-25 | 2024-04-02 | 海门瑞一医药科技有限公司 | 一种4-羟基丁腈的合成方法 |
| US12357577B1 (en) | 2024-02-02 | 2025-07-15 | Gilead Sciences, Inc. | Pharmaceutical formulations and uses thereof |
Family Cites Families (155)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816570A (en) | 1982-11-30 | 1989-03-28 | The Board Of Regents Of The University Of Texas System | Biologically reversible phosphate and phosphonate protective groups |
| US4968788A (en) | 1986-04-04 | 1990-11-06 | Board Of Regents, The University Of Texas System | Biologically reversible phosphate and phosphonate protective gruops |
| DE69115694T2 (de) | 1990-06-13 | 1996-10-17 | Arnold Newton Mass. Glazier | Phosphorylierte prodrugs |
| DE10399025I2 (de) | 1990-09-14 | 2007-11-08 | Acad Of Science Czech Republic | Wirkstoffvorläufer von Phosphonaten |
| JPH1017629A (ja) | 1996-07-04 | 1998-01-20 | Kayaku Akzo Kk | ハードコート用樹脂組成物及びその硬化方法 |
| US6887707B2 (en) | 1996-10-28 | 2005-05-03 | University Of Washington | Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| IL137353A0 (en) | 1998-03-03 | 2001-07-24 | Novo Nordisk As | New salt forms of (2e) -5- amino-5-methylhex -2- enoic acid n-methyl -n- ((1r) -1-(n-methyl -n- ((1r) -1-(methylcarbamoyl) -2- phenylethyl) carbamoyl)-2-(2-naphthyl)ethyl)amid |
| US6312662B1 (en) | 1998-03-06 | 2001-11-06 | Metabasis Therapeutics, Inc. | Prodrugs phosphorus-containing compounds |
| CA2326535A1 (en) | 1998-03-27 | 1999-10-07 | Regents Of The University Of Minnesota | Nucleosides with antiviral and anticancer activity |
| EP1121361B1 (en) | 1998-10-16 | 2007-08-29 | Merck Sharp & Dohme Limited | Pyrazolo-triazine derivatives as ligands for gaba receptors |
| DE19912636A1 (de) | 1999-03-20 | 2000-09-21 | Aventis Cropscience Gmbh | Bicyclische Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und pharmazeutische Mittel |
| AU3418800A (en) * | 1999-03-24 | 2000-10-09 | Exiqon A/S | Improved synthesis of (2.2.1)bicyclo nucleosides |
| WO2000075157A1 (en) * | 1999-06-03 | 2000-12-14 | Abbott Laboratories | Oligonucleotide synthesis with lewis acids as activators |
| AUPQ105499A0 (en) | 1999-06-18 | 1999-07-08 | Biota Scientific Management Pty Ltd | Antiviral agents |
| WO2001019375A1 (en) | 1999-09-15 | 2001-03-22 | Biocryst Pharmaceuticals, Inc. | Inhibiting t-cell proliferation |
| US6566365B1 (en) | 1999-11-04 | 2003-05-20 | Biochem Pharma Inc. | Method for the treatment of Flaviviridea viral infection using nucleoside analogues |
| PL364995A1 (en) | 2000-02-18 | 2004-12-27 | Shire Biochem Inc. | Method for the treatment or prevention of flavivirus |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| KR20080021797A (ko) | 2000-05-26 | 2008-03-07 | 이데닉스(케이만)리미티드 | 플라비바이러스 및 페스티바이러스의 치료방법 및 조성물 |
| NZ536942A (en) | 2000-07-21 | 2006-03-31 | Gilead Sciences Inc | Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| US20030008841A1 (en) | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| PT2251015E (pt) | 2000-10-18 | 2013-04-15 | Gilead Pharmasset Llc | Nucleosídeos modificados para o tratamento de infeções virais e de proliferação celular anormal |
| AUPR213700A0 (en) | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
| BR0206614A (pt) | 2001-01-22 | 2004-02-17 | Merck & Co Inc | Composto, composição farmacêutica, método para inibir a polimerase viral de rna dependente de rna e/ou inibir a replicação viral de rna dependente de rna, método para tratar uma infecção viral de rna dependente de rna, e, uso de um composto |
| DE10145223A1 (de) | 2001-09-13 | 2003-04-03 | Basf Ag | Verfahren zur Herstellung von meso-Zeaxanthin |
| US20040006002A1 (en) | 2001-09-28 | 2004-01-08 | Jean-Pierre Sommadossi | Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
| AT410792B (de) | 2001-12-28 | 2003-07-25 | Dsm Fine Chem Austria Gmbh | Verfahren zur herstellung von geschützten, enantiomeren-angereicherten cyanhydrinen durch in-situ-derivatisierung |
| AU2003217863B9 (en) | 2002-02-28 | 2009-10-29 | Biota Scientific Management Pty Ltd | Nucleotide mimics and their prodrugs |
| CA2477795A1 (en) | 2002-02-28 | 2003-09-12 | Kandasamy Sakthivel | Nucleoside 5'-monophosphate mimics and their prodrugs |
| US20040138170A1 (en) | 2002-03-06 | 2004-07-15 | Montgomery John A. | Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases |
| GB0210124D0 (en) | 2002-05-02 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
| GB0210127D0 (en) | 2002-05-02 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
| MXPA04010983A (es) | 2002-05-06 | 2005-02-14 | Genelabs Tech Inc | Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c. |
| WO2003100009A2 (en) | 2002-05-23 | 2003-12-04 | Biocryst Pharmaceuticals, Inc. | Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof |
| US7824851B2 (en) | 2002-11-15 | 2010-11-02 | Idenix Pharmaceuticals, Inc. | 2′-branched nucleosides and Flaviviridae mutation |
| PT1628685E (pt) | 2003-04-25 | 2011-03-16 | Gilead Sciences Inc | Análogos de fosfonatos antivirais |
| JP5030587B2 (ja) | 2003-06-26 | 2012-09-19 | バイオトロン・リミテッド | 抗ウイルスアシルグアニジン化合物および方法 |
| GB0317009D0 (en) | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
| RU2006105640A (ru) | 2003-07-25 | 2007-09-10 | Айденикс (Кайман) Лимитед (Ky) | Аналоги пуриновых нуклеозидов для лечения flaviviridae, включая гепатит с |
| WO2005021568A2 (en) | 2003-08-27 | 2005-03-10 | Biota, Inc. | Novel tricyclic nucleosides or nucleotides as therapeutic agents |
| JP2005185235A (ja) * | 2003-12-26 | 2005-07-14 | Univ Of Tokyo | ウイルス感染に対する感受性診断のための方法およびキット。 |
| JP2005187428A (ja) * | 2003-12-26 | 2005-07-14 | Univ Of Tokyo | 抗ｍｇｌ抗体によるフィロウイルス治療薬 |
| CN103435581B (zh) * | 2004-03-16 | 2015-08-19 | 贝林格尔.英格海姆国际有限公司 | 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法 |
| EP1758453B1 (en) | 2004-06-15 | 2014-07-16 | Merck Sharp & Dohme Corp. | C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| US7560434B2 (en) | 2004-06-22 | 2009-07-14 | Biocryst Pharmaceuticals, Inc. | AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| WO2006031725A2 (en) | 2004-09-14 | 2006-03-23 | Pharmasset, Inc. | Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
| AU2005317081A1 (en) | 2004-10-21 | 2006-06-22 | Merck & Co., Inc. | Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of RNA-dependent RNA viral infection |
| CN101043893A (zh) | 2004-10-21 | 2007-09-26 | 默克公司 | 治疗RNA－依赖性RNA病毒感染的氟化吡咯并[2,3－d]嘧啶核苷 |
| US8133870B2 (en) | 2004-10-29 | 2012-03-13 | Biocryst Pharmaceuticals, Inc. | Therapeutic furopyrimidines and thienopyrimidines |
| EP1828216B1 (en) | 2004-12-16 | 2008-09-10 | Boehringer Ingelheim International GmbH | Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| WO2006094347A1 (en) | 2005-03-08 | 2006-09-14 | Biota Scientific Management Pty Ltd. | Bicyclic nucleosides and nucleotides as therapeutic agents |
| CA2602533A1 (en) | 2005-03-29 | 2006-10-05 | Biocryst Pharmaceuticals, Inc. | Use of c-nucleoside analogs for treatment of hepatitis c related viral infections |
| WO2006116557A1 (en) | 2005-04-25 | 2006-11-02 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
| WO2006121820A1 (en) | 2005-05-05 | 2006-11-16 | Valeant Research & Development | Phosphoramidate prodrugs for treatment of viral infection |
| WO2007027248A2 (en) | 2005-05-16 | 2007-03-08 | Valeant Research & Development | 3', 5' - cyclic nucleoside analogues for treatment of hcv |
| PT2826770T (pt) | 2005-06-24 | 2018-12-18 | Biotron Ltd | Compostos acilguanidinas com atividade antiviral |
| WO2007038860A2 (en) | 2005-10-03 | 2007-04-12 | University Health Network | Odcase inhibitors as anti-virals and antibiotics |
| EP1945222B1 (en) | 2005-11-02 | 2012-12-26 | Bayer Pharma Aktiengesellschaft | Pyrrolo[2,1-f] [1,2,4]-triazin-4-ylamines as igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
| DE602006009698D1 (de) | 2005-12-01 | 2009-11-19 | Basilea Pharmaceutica Ag | Verfahren zur herstellung von expoxybutanol-zwischenprodukten |
| CN101466710B (zh) | 2005-12-02 | 2013-05-29 | 拜尔健康护理有限责任公司 | 用于治疗与血管生成有关的过度增殖性病症和疾病的取代的4-氨基-吡咯并三嗪衍生物 |
| PE20070855A1 (es) | 2005-12-02 | 2007-10-14 | Bayer Pharmaceuticals Corp | Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas |
| EP1957510A1 (en) | 2005-12-09 | 2008-08-20 | F.Hoffmann-La Roche Ag | Antiviral nucleosides |
| EP1971331A2 (en) | 2005-12-09 | 2008-09-24 | Basilea Pharmaceutica AG | 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders |
| WO2007097991A2 (en) | 2006-02-16 | 2007-08-30 | Pharmasset, Inc. | Methods and kits for dosing of antiviral agents |
| DE102006015378A1 (de) * | 2006-04-03 | 2007-10-04 | Ludwig-Maximilians-Universität München | Verfahren zur Synthese von Organoelementverbindungen |
| AR061024A1 (es) | 2006-05-22 | 2008-07-30 | Novartis Ag | Maleato de 5-amino-3- (2'3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d] pirimidin-2-ona. |
| WO2008005542A2 (en) | 2006-07-07 | 2008-01-10 | Gilead Sciences, Inc., | Antiviral phosphinate compounds |
| US20080161324A1 (en) | 2006-09-14 | 2008-07-03 | Johansen Lisa M | Compositions and methods for treatment of viral diseases |
| JP2010508371A (ja) * | 2006-11-06 | 2010-03-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グルコピラノシル置換フェニル誘導体、該化合物を含有する医薬品及びその使用と製造方法 |
| WO2008079206A1 (en) | 2006-12-20 | 2008-07-03 | Merck & Co., Inc. | Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection |
| US7951789B2 (en) | 2006-12-28 | 2011-05-31 | Idenix Pharmaceuticals, Inc. | Compounds and pharmaceutical compositions for the treatment of viral infections |
| US8071568B2 (en) | 2007-01-05 | 2011-12-06 | Merck Sharp & Dohme Corp. | Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection |
| SI2114980T1 (sl) | 2007-01-12 | 2012-11-30 | Biocryst Pharm Inc | Protivirusni nukleozidni analogi |
| US8188272B2 (en) | 2007-03-21 | 2012-05-29 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
| JP2011513195A (ja) | 2007-05-10 | 2011-04-28 | バイオクライスト ファーマシューティカルズ， インコーポレイテッド | ウイルス感染およびがんの処置に使用するためのテトラヒドロフロ［３，４−ｄ］ジオキソラン化合物 |
| CN100532388C (zh) | 2007-07-16 | 2009-08-26 | 郑州大学 | 2’-氟-4’-取代-核苷类似物、其制备方法及应用 |
| BRPI0814737B8 (pt) | 2007-08-03 | 2021-05-25 | Biotron Ltd | composição para o tratamento de hcv, e, uso de uma composição |
| KR101502533B1 (ko) | 2007-11-22 | 2015-03-13 | 에스케이케미칼주식회사 | 우수한 안정성을 갖는 택산 유도체 함유 주사제용동결건조 조성물 및 이의 제조방법 |
| TW200942243A (en) | 2008-03-05 | 2009-10-16 | Biocryst Pharm Inc | Antiviral therapeutic agents |
| US8227431B2 (en) | 2008-03-17 | 2012-07-24 | Hetero Drugs Limited | Nucleoside derivatives |
| US7863291B2 (en) | 2008-04-23 | 2011-01-04 | Bristol-Myers Squibb Company | Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| AP3076A (en) | 2008-04-23 | 2014-12-31 | Gilead Sciences Inc | Carba-nucleoside analogs for antiviral treatment |
| WO2010036407A2 (en) | 2008-05-15 | 2010-04-01 | Biocryst Pharmaceuticals, Inc. | Antiviral nucleoside analogs |
| WO2010002877A2 (en) | 2008-07-03 | 2010-01-07 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| CN102348713B (zh) | 2009-02-10 | 2015-12-02 | 吉里德科学公司 | 用于抗病毒治疗的carba-核苷类似物 |
| AR075584A1 (es) | 2009-02-27 | 2011-04-20 | Intermune Inc | COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO. |
| EP2408306A4 (en) | 2009-03-20 | 2012-11-07 | Alios Biopharma Inc | SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGUES |
| US8501753B2 (en) | 2009-03-24 | 2013-08-06 | Biocryst Pharmaceuticals, Inc. | Useful pharmaceutical salts of 7-[(3R, 4R)-3-Hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3, 5-dihydro-pyrrolo [3, 2-D] pyrimidin-4-one |
| TWI598358B (zh) | 2009-05-20 | 2017-09-11 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
| TW201116525A (en) | 2009-07-21 | 2011-05-16 | Gilead Sciences Inc | Inhibitors of flaviviridae viruses |
| EA201200525A1 (ru) | 2009-09-21 | 2012-09-28 | Гайлид Сайэнсиз, Инк. | 2'-фторзамещенные карба-нуклеозидные аналоги для противовирусного лечения |
| US7973013B2 (en) | 2009-09-21 | 2011-07-05 | Gilead Sciences, Inc. | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| EP2480559B1 (en) | 2009-09-21 | 2013-07-03 | Gilead Sciences, Inc. | Processes and intermediates for the preparation of 1'-cyano-carbanucleoside analogs |
| US8455451B2 (en) | 2009-09-21 | 2013-06-04 | Gilead Sciences, Inc. | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| TWI555746B (zh) | 2009-12-28 | 2016-11-01 | 財團法人生物技術開發中心 | 作為ｍＴＯＲ及ＰＩ３Ｋ抑制劑之新穎嘧啶化合物 |
| TW201136945A (en) | 2010-03-31 | 2011-11-01 | Pharmasset Inc | Purine nucleoside phosphoramidate |
| LT2609923T (lt) | 2010-03-31 | 2017-09-11 | Gilead Pharmasset Llc | (s)-izopropilo 2-(((s)-(perfluorfenoksi)(fenoksi)fosforil)amino)-propanoato kristalinimo būdas |
| TW201201815A (en) | 2010-05-28 | 2012-01-16 | Gilead Sciences Inc | 1'-substituted-carba-nucleoside prodrugs for antiviral treatment |
| EP2596004B1 (en) * | 2010-07-19 | 2014-09-10 | Gilead Sciences, Inc. | Methods for the preparation of diasteromerically pure phosphoramidate prodrugs |
| PT2595980E (pt) | 2010-07-22 | 2014-11-27 | Gilead Sciences Inc | Métodos e compostos para tratar infeções pelo vírus da família paramyxoviridae |
| TW201305185A (zh) * | 2010-09-13 | 2013-02-01 | Gilead Sciences Inc | 用於抗病毒治療之２’－氟取代之碳－核苷類似物 |
| CA2807496C (en) | 2010-09-20 | 2019-01-22 | Gilead Sciences, Inc. | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| CA2810928A1 (en) | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| PL2898885T3 (pl) | 2010-10-15 | 2018-04-30 | Biocryst Pharmaceuticals, Inc. | Pochodne pirolopirymidynowe do zastosowania w leczeniu zakażeń wirusowych |
| US8841275B2 (en) | 2010-11-30 | 2014-09-23 | Gilead Pharmasset Llc | 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections |
| TW201701876A (zh) | 2010-12-20 | 2017-01-16 | 吉李德科學股份有限公司 | 治療ｃ型肝炎病毒（ｈｃｖ）之方法 |
| CA2830689A1 (en) | 2011-04-13 | 2012-10-18 | Gilead Sciences, Inc. | 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment |
| PE20140522A1 (es) | 2011-04-13 | 2014-05-03 | Merck Sharp & Dohme | Derivados de nucleosidos 2'- sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales |
| MX352604B (es) * | 2011-05-13 | 2017-11-30 | Zoetis Llc | Composiciones inmunogenicas de la glucoproteina g de los virus hendra y nipah. |
| EP3384938A1 (en) * | 2011-09-12 | 2018-10-10 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| CA2840242C (en) | 2011-09-16 | 2019-03-26 | Gilead Sciences, Inc. | Methods for treating hcv |
| US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
| WO2013084165A1 (en) | 2011-12-05 | 2013-06-13 | Medivir Ab | Hcv polymerase inhibitors |
| US20130143835A1 (en) * | 2011-12-05 | 2013-06-06 | Medivir Ab | HCV Polymerase Inhibitors |
| US8980865B2 (en) * | 2011-12-22 | 2015-03-17 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| JP6165848B2 (ja) | 2012-05-22 | 2017-07-19 | イデニク ファーマシューティカルズ エルエルシー | 肝疾患のためのｄ−アミノ酸化合物 |
| US9556216B2 (en) | 2012-08-31 | 2017-01-31 | Novartis Ag | 2′-Ethynyl nucleoside derivatives for treatment of viral infections |
| WO2014037480A1 (en) | 2012-09-10 | 2014-03-13 | F. Hoffmann-La Roche Ag | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
| WO2014042433A2 (en) * | 2012-09-14 | 2014-03-20 | Kainos Medicine, Inc. | Compounds and compositions for modulating adenosine a3 receptor activity |
| US20150291596A1 (en) | 2012-11-16 | 2015-10-15 | Biocryst Pharmaceuticals, Inc. | Antiviral azasugar-containing nucleosides |
| WO2014078463A1 (en) | 2012-11-19 | 2014-05-22 | Merck Sharp & Dohme Corp. | 2 -alkynyl substituted nucleoside derivatives for treating viral diseases |
| EA201590943A1 (ru) * | 2012-12-21 | 2016-01-29 | Алиос Биофарма, Инк. | Замещенные нуклеозиды, нуклеотиды и их аналоги |
| WO2014116755A1 (en) | 2013-01-22 | 2014-07-31 | Massachusetts Institute Of Technology | Uses of dihydro bases |
| US10034893B2 (en) | 2013-02-01 | 2018-07-31 | Enanta Pharmaceuticals, Inc. | 5, 6-D2 uridine nucleoside/tide derivatives |
| AU2014250764A1 (en) | 2013-04-12 | 2015-10-29 | Achillion Pharmaceuticals, Inc. | Deuterated nucleoside prodrugs useful for treating HCV |
| US9542154B2 (en) | 2013-06-25 | 2017-01-10 | Intel Corporation | Fused multiply add operations using bit masks |
| UA117375C2 (uk) * | 2013-09-04 | 2018-07-25 | Медівір Аб | Інгібітори полімерази hcv |
| HRP20201953T1 (hr) | 2013-09-11 | 2021-04-30 | Institut National De La Santé Et De La Recherche Médicale (Inserm) | Postupci i farmaceutski pripravci za liječenje virusne infekcije hepatitisom b |
| UA119050C2 (uk) * | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
| CA2931329A1 (en) | 2014-01-30 | 2015-08-06 | F. Hoffmann-La Roche Ag | Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection |
| RS58384B1 (sr) | 2014-03-07 | 2019-04-30 | Hoffmann La Roche | Novi 6-fuzionisani heteroarildihidropirimidini za lečenje i profilaksu infekcije virusom hepatitisa b |
| KR20160148715A (ko) | 2014-05-13 | 2016-12-26 | 에프. 호프만-라 로슈 아게 | B형 간염 바이러스 감염의 치료 또는 예방을 위한 신규한 다이하이드로퀴놀리진온 |
| US9504701B2 (en) | 2014-06-02 | 2016-11-29 | The Board Of Regents Of The University Of Texas System | Methods for treating viral infections using hydrogen sulfide donors |
| US9616076B2 (en) * | 2014-06-02 | 2017-04-11 | The Board Of Regents Of The University Of Texas Systems | Methods for treating viral infections using hydrogen sulfide donors |
| WO2016012470A1 (en) | 2014-07-25 | 2016-01-28 | F. Hoffmann-La Roche Ag | New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid |
| EP3180319B1 (en) | 2014-08-14 | 2018-10-03 | F.Hoffmann-La Roche Ag | Novel pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection |
| TWI740546B (zh) | 2014-10-29 | 2021-09-21 | 美商基利科學股份有限公司 | 製備核糖苷的方法 |
| US9637485B2 (en) | 2014-11-03 | 2017-05-02 | Hoffmann-La Roche Inc. | 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection |
| US9676793B2 (en) | 2014-12-23 | 2017-06-13 | Hoffmann-Laroche Inc. | Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same |
| AR103222A1 (es) | 2014-12-23 | 2017-04-26 | Hoffmann La Roche | Procedimiento para la preparación de análogos de 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidina |
| JP6506845B2 (ja) | 2014-12-30 | 2019-04-24 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂ型肝炎ウイルス感染症の治療及び予防のための新規テトラヒドロピリドピリミジン類及びテトラヒドロピリドピリジン類 |
| WO2016107833A1 (en) | 2014-12-31 | 2016-07-07 | F. Hoffmann-La Roche Ag | A novel high-throughput method for quantification of hbv cccdna from cell lysate by real-time pcr |
| MA41338B1 (fr) | 2015-01-16 | 2019-07-31 | Hoffmann La Roche | Composés de pyrazine pour le traitement de maladies infectieuses |
| EP3250685A1 (en) | 2015-01-27 | 2017-12-06 | F. Hoffmann-La Roche AG | Recombinant hbv cccdna, the method to generate thereof and the use thereof |
| HK1244281B (zh) | 2015-02-11 | 2020-02-07 | F. Hoffmann-La Roche Ag | 治疗和预防乙型肝炎病毒感染的2-氧代-6，7-二氢苯并[a]喹嗪-3-甲酸衍生物 |
| PL3349758T3 (pl) | 2015-09-16 | 2022-09-12 | Gilead Sciences, Inc. | Sposoby leczenia zakażeń wirusami arenaviridae |
| WO2017184668A1 (en) | 2016-04-20 | 2017-10-26 | Gilead Sciences, Inc. | Methods for treating flaviviridae virus infections |
| ES2910136T3 (es) | 2017-02-08 | 2022-05-11 | Biotron Ltd | Métodos de tratamiento de la gripe |
| KR102460968B1 (ko) | 2017-03-14 | 2022-11-01 | 길리애드 사이언시즈, 인코포레이티드 | 고양이 코로나바이러스 감염의 치료 방법 |
| JP2020518578A (ja) | 2017-05-01 | 2020-06-25 | ギリアード サイエンシーズ， インコーポレイテッド | （Ｓ）−２−エチルブチル２−（（（Ｓ）−（（（２Ｒ，３Ｓ，４Ｒ，５Ｒ）−５−（４−アミノピロロ［２，１−ｆ］［１，２，４］トリアジン−７−イル）−５−シアノ−３，４−ジヒドロキシテトラヒドロフラン−２−イル）メトキシ）（フェノキシ）ホスホリル）アミノ）プロパノエートの結晶形態 |
| CA3077489A1 (en) | 2017-07-11 | 2019-01-17 | Gilead Sciences, Inc. | Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections |
| CN111265532A (zh) | 2020-01-21 | 2020-06-12 | 中国人民解放军军事科学院军事医学研究院 | 取代氨基丙酸酯类化合物在治疗2019-nCoV感染中的应用 |
| CN118766947A (zh) | 2020-01-27 | 2024-10-15 | 吉利德科学公司 | 用于治疗SARS CoV-2感染的方法 |
| TWI890963B (zh) * | 2020-03-12 | 2025-07-21 | 美商基利科學股份有限公司 | 1'-氰基核苷之製備方法 |
-
2015
- 2015-10-27 TW TW109120726A patent/TWI740546B/zh active
- 2015-10-27 TW TW104135247A patent/TWI687432B/zh active
- 2015-10-27 TW TW109109475A patent/TWI767201B/zh active
- 2015-10-27 TW TW104135248A patent/TWI698444B/zh active
- 2015-10-28 BR BR102015027413A patent/BR102015027413A2/pt not_active Application Discontinuation
- 2015-10-29 EP EP20152978.1A patent/EP3695844B1/en active Active
- 2015-10-29 PL PL15797205T patent/PL3212174T3/pl unknown
- 2015-10-29 ES ES20152978T patent/ES3026734T3/es active Active
- 2015-10-29 AR ARP150103506A patent/AR102468A1/es unknown
- 2015-10-29 US US14/926,062 patent/US9724360B2/en active Active
- 2015-10-29 KR KR1020177014043A patent/KR102694960B1/ko active Active
- 2015-10-29 PT PT181673401T patent/PT3366295T/pt unknown
- 2015-10-29 NZ NZ745328A patent/NZ745328A/en unknown
- 2015-10-29 PL PL20152978.1T patent/PL3695844T3/pl unknown
- 2015-10-29 EP EP15797205.0A patent/EP3212174B1/en active Active
- 2015-10-29 KR KR1020247026762A patent/KR20240125990A/ko active Pending
- 2015-10-29 SI SI201532063T patent/SI3695844T1/sl unknown
- 2015-10-29 AU AU2015339222A patent/AU2015339222B2/en active Active
- 2015-10-29 ES ES15797205.0T patent/ES2674806T3/es active Active
- 2015-10-29 CN CN202111480947.3A patent/CN114191438A/zh active Pending
- 2015-10-29 EP EP15801008.2A patent/EP3212175B1/en active Active
- 2015-10-29 PT PT158010082T patent/PT3212175T/pt unknown
- 2015-10-29 NZ NZ730809A patent/NZ730809A/en unknown
- 2015-10-29 SG SG11201702904RA patent/SG11201702904RA/en unknown
- 2015-10-29 MD MDA20170046A patent/MD20170046A2/ro not_active Application Discontinuation
- 2015-10-29 EP EP21209687.9A patent/EP4036099B1/en active Active
- 2015-10-29 EP EP25164258.3A patent/EP4591935A2/en active Pending
- 2015-10-29 HU HUE15797205A patent/HUE039231T2/hu unknown
- 2015-10-29 EA EA201790630A patent/EA201790630A1/ru unknown
- 2015-10-29 MA MA040867A patent/MA40867A/fr unknown
- 2015-10-29 KR KR1020227034888A patent/KR20220140656A/ko not_active Withdrawn
- 2015-10-29 US US14/926,063 patent/US11344565B2/en active Active
- 2015-10-29 UA UAA201703584A patent/UA121485C2/uk unknown
- 2015-10-29 ME MEP-2018-183A patent/ME03070B/me unknown
- 2015-10-29 EP EP25167754.8A patent/EP4588928A3/en active Pending
- 2015-10-29 HR HRP20181130TT patent/HRP20181130T1/hr unknown
- 2015-10-29 JP JP2017520938A patent/JP6220484B1/ja active Active
- 2015-10-29 PL PL18167340T patent/PL3366295T3/pl unknown
- 2015-10-29 SI SI201530258T patent/SI3212174T1/en unknown
- 2015-10-29 CU CUP2017000145A patent/CU20170145A7/xx unknown
- 2015-10-29 HU HUE18167340A patent/HUE049192T2/hu unknown
- 2015-10-29 PE PE2017000745A patent/PE20171439A1/es unknown
- 2015-10-29 PL PL21209687.9T patent/PL4036099T3/pl unknown
- 2015-10-29 JP JP2017520934A patent/JP6487547B2/ja active Active
- 2015-10-29 PT PT201529781T patent/PT3695844T/pt unknown
- 2015-10-29 WO PCT/US2015/057933 patent/WO2016069826A1/en not_active Ceased
- 2015-10-29 LT LTEP18167340.1T patent/LT3366295T/lt unknown
- 2015-10-29 BR BR112017007636A patent/BR112017007636A2/pt not_active Application Discontinuation
- 2015-10-29 CR CR20170483A patent/CR20170483A/es unknown
- 2015-10-29 ES ES21209687T patent/ES3020561T3/es active Active
- 2015-10-29 CA CA3184285A patent/CA3184285A1/en active Pending
- 2015-10-29 EA EA201790597A patent/EA032239B1/ru unknown
- 2015-10-29 KR KR1020177014110A patent/KR102337664B1/ko active Active
- 2015-10-29 AU AU2015339223A patent/AU2015339223B2/en active Active
- 2015-10-29 KR KR1020217039965A patent/KR102453808B1/ko active Active
- 2015-10-29 RS RS20180822A patent/RS57425B1/sr unknown
- 2015-10-29 ES ES18167340T patent/ES2785034T3/es active Active
- 2015-10-29 CA CA2963832A patent/CA2963832C/en active Active
- 2015-10-29 CN CN202110878274.0A patent/CN113549120B/zh active Active
- 2015-10-29 SM SM20180381T patent/SMT201800381T1/it unknown
- 2015-10-29 PH PH1/2017/500631A patent/PH12017500631B1/en unknown
- 2015-10-29 MX MX2017005252A patent/MX2017005252A/es unknown
- 2015-10-29 SG SG11201702903TA patent/SG11201702903TA/en unknown
- 2015-10-29 MA MA052506A patent/MA52506A/fr unknown
- 2015-10-29 CN CN201580059613.5A patent/CN107074902A/zh active Pending
- 2015-10-29 PL PL15801008T patent/PL3212175T3/pl unknown
- 2015-10-29 CN CN202111041161.1A patent/CN113620992B/zh active Active
- 2015-10-29 WO PCT/US2015/057934 patent/WO2016069827A1/en not_active Ceased
- 2015-10-29 LT LTEP15797205.0T patent/LT3212174T/lt unknown
- 2015-10-29 CU CUP2017000056A patent/CU20170056A7/es unknown
- 2015-10-29 SG SG10202008772UA patent/SG10202008772UA/en unknown
- 2015-10-29 DK DK18167340.1T patent/DK3366295T3/da active
- 2015-10-29 KR KR1020177014042A patent/KR101822348B1/ko active Active
- 2015-10-29 EP EP18167340.1A patent/EP3366295B1/en active Active
- 2015-10-29 DK DK15797205.0T patent/DK3212174T3/en active
- 2015-10-29 NZ NZ730803A patent/NZ730803A/en unknown
- 2015-10-29 CN CN202410806375.0A patent/CN118812607A/zh active Pending
- 2015-10-29 ES ES15801008T patent/ES2904298T3/es active Active
- 2015-10-29 MY MYPI2017701244A patent/MY195823A/en unknown
- 2015-10-29 CA CA2963907A patent/CA2963907C/en active Active
- 2015-10-29 SI SI201531150T patent/SI3366295T1/sl unknown
- 2015-10-29 UY UY0001036376A patent/UY36376A/es unknown
- 2015-10-29 WO PCT/US2015/057932 patent/WO2016069825A1/en not_active Ceased
- 2015-10-29 TR TR2018/09518T patent/TR201809518T4/tr unknown
- 2015-10-29 MA MA040872A patent/MA40872A/fr unknown
- 2015-10-29 CR CR20170165A patent/CR20170165A/es unknown
- 2015-10-29 PE PE2017002319A patent/PE20180202A1/es unknown
- 2015-10-29 AR ARP150103505A patent/AR102467A1/es not_active Application Discontinuation
- 2015-10-29 MX MX2017005250A patent/MX378299B/es unknown
- 2015-10-29 PT PT157972050T patent/PT3212174T/pt unknown
- 2015-10-29 CN CN201580059611.6A patent/CN107073005B/zh active Active
- 2015-10-29 SI SI201531764T patent/SI3212175T1/sl unknown
-
2016
- 2016-08-24 US US15/246,240 patent/US9949994B2/en active Active
-
2017
- 2017-04-04 IL IL251560A patent/IL251560A0/en unknown
- 2017-04-12 IL IL251707A patent/IL251707B/en active IP Right Grant
- 2017-04-21 MX MX2020012560A patent/MX2020012560A/es unknown
- 2017-04-24 SV SV2017005424A patent/SV2017005424A/es unknown
- 2017-04-24 EC ECIEPI201725261A patent/ECSP17025261A/es unknown
- 2017-04-24 CO CONC2017/0003960A patent/CO2017003960A2/es unknown
- 2017-04-24 DO DO2017000103A patent/DOP2017000103A/es unknown
- 2017-04-26 CL CL2017001040A patent/CL2017001040A1/es unknown
- 2017-04-27 SA SA517381419A patent/SA517381419B1/ar unknown
- 2017-06-06 JP JP2017111470A patent/JP6757294B2/ja active Active
- 2017-10-24 CL CL2017002693A patent/CL2017002693A1/es unknown
- 2017-10-30 EC ECIEPI201772474A patent/ECSP17072474A/es unknown
- 2017-11-01 UY UY0001037464A patent/UY37464A/es not_active Application Discontinuation
- 2017-11-03 SV SV2017005561A patent/SV2017005561A/es unknown
-
2018
- 2018-01-19 ZA ZA201800414A patent/ZA201800414B/en unknown
- 2018-02-22 US US15/902,690 patent/US10251898B2/en active Active
- 2018-07-06 JP JP2018129006A patent/JP6671424B2/ja active Active
- 2018-08-10 CY CY20181100844T patent/CY1120893T1/el unknown
- 2018-10-23 AU AU2018253483A patent/AU2018253483B2/en active Active
-
2019
- 2019-01-07 JP JP2019000664A patent/JP2019048901A/ja not_active Withdrawn
- 2019-02-12 US US16/274,049 patent/US10695357B2/en active Active
- 2019-02-22 AU AU2019201232A patent/AU2019201232B2/en active Active
- 2019-11-22 US US16/692,966 patent/US20200197422A1/en not_active Abandoned
-
2020
- 2020-02-14 JP JP2020023613A patent/JP2020090536A/ja not_active Withdrawn
- 2020-03-06 JP JP2020038878A patent/JP7158428B2/ja active Active
- 2020-04-14 CY CY20201100351T patent/CY1122946T1/el unknown
- 2020-05-22 US US16/881,419 patent/US11266666B2/en active Active
- 2020-06-12 AU AU2020203892A patent/AU2020203892A1/en not_active Abandoned
- 2020-07-08 PH PH12020551055A patent/PH12020551055A1/en unknown
-
2021
- 2021-03-09 AU AU2021201474A patent/AU2021201474B2/en active Active
-
2022
- 2022-02-07 US US17/665,724 patent/US20220354873A1/en not_active Abandoned
- 2022-02-10 JP JP2022019651A patent/JP2022065066A/ja not_active Withdrawn
- 2022-02-18 JP JP2022024119A patent/JP2022068297A/ja active Pending
- 2022-12-09 AU AU2022283772A patent/AU2022283772A1/en not_active Abandoned
-
2023
- 2023-05-02 AU AU2023202679A patent/AU2023202679A1/en not_active Abandoned